Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000439 · ClinicalTrials.gov registry record · Phase 2
Drug Treatment for Alcoholics With Bipolar Disorder
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT00000439 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 72 participants.
The verdict
NCT00000439, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in treating individuals with alcohol dependence and comorbid bipolar disorder.
Interventions
- DRUG sodium valproate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2000-10 |
| Est. Completion | 2003-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000439
The ClinicalTrials.gov registry entry for NCT00000439 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium valproate is the first listed.
NCT00000439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000439 about?
NCT00000439 is a clinical study titled "Drug Treatment for Alcoholics With Bipolar Disorder". The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in treating individuals with alcohol dependence and comorbid bipolar disorder.
What is the current status of trial NCT00000439?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2000-10. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00000439?
The interventions under investigation include: sodium valproate (DRUG).
Who is sponsoring clinical trial NCT00000439?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.